Zepp Health Corporation, a biometric and activity data-driven company, develops, manufactures, and sells smart wearable technological devices in the People's Republic of China. It operates through two segments, Xiaomi Wearable Products, and Self-Branded Products and Others. The company offers smart bands, watches, and scales; and a range of accessories, including bands, watch straps, earphones, sportswear, home gym, treadmill, etc. under the Xiaomi and Amazfit brands. It provides charts and graphs to display analysis of the activity and biometric data collected from users through its Mi Fit and Amazfit mobile apps. Zepp Health Corporation has strategic collaborations with Timex Group to develop smart watches; and AliveCor, Inc. to deliver a medical functionality to wearable devices. The company was formerly known as Huami Corporation and changed its name to Zepp Health Corporation in February 2021. Zepp Health Corporation was founded in 2013 and is headquartered in Hefei, the People's Republic of China.
IPO Year:
Exchange: NYSE
Website: https://www.huami.com
MILPITAS, Calif., Nov. 18, 2024 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE:ZEPP) today reported revenues of US$42.5 million; a basic and diluted net loss per share of US$0.05; and a basic and diluted net loss per ADS of US$0.82 for the third quarter ended September 30, 2024; adjusted basic and diluted net loss per share of US$0.05; and adjusted basic and diluted net loss per ADS of US$0.78. Each ADS represents sixteen Class A ordinary shares. Mr. Wang 'Wayne' Huang, Chairman and CEO of Zepp, commented, "I'm pleased to report that this quarter our Amazfit branded sales had a 10% quarter-over-quarter increase, the highest sequential growth we've achieved this year
Earnings Call Scheduled for 8:30 p.m. ET on November 18, 2024 MILPITAS, Calif., Nov. 5, 2024 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE:ZEPP), a global leader in smart wearables and health technology, today announced that it will report its third quarter 2024 unaudited financial results after the market close on Monday, November 18, 2024. Management will hold a conference call at 8:30 p.m. Eastern Time on Monday, November 18, 2024. Listeners may access the call by dialing: US (Toll Free): +1-888-346-8982 International: +1-412-902-4272 Mainland China (Toll Free): 400-120-1203 Hong Kong (Toll Free): 800-905-945 Hong Kong: +852-3018-4992 Participants should
MILPITAS, Calif., Oct. 31, 2024 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health") (NYSE:ZEPP), a global leader in smart wearables and health technology, today announced the launch of the enhanced Zepp App 9. This latest app version is designed to deliver a more personalized health, wellness, and fitness experience, empowering Amazfit users worldwide to understand their health trends and make informed lifestyle decisions. Zepp App 9 is available on iOS and Android platforms and compatible with all Amazfit devices. Key Enhancements in Zepp App 9: A New, Improved Free Zepp App Core Experience Enhanced User Interface: The new, streamlined interface features color-coded statistics, daily s
MILPITAS, Calif., Oct. 2, 2024 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE:ZEPP), a global leader in smart wearables and health technology, today announced that it has received a letter from the New York Stock Exchange ("NYSE") dated October 2, 2024 (the "October Letter"), notifying the Company that it has regained compliance with the NYSE's continued listing criterion of a minimum share price as set forth in Section 802.01C of the NYSE Listed Company Manual (the "NYSE Minimum Price Continued Listing Criterion"). As previously announced, the Company received a letter from the NYSE dated April 30, 2024, notifying the Company that it was below compliance sta
Zepp Health's Amazfit smartwatches and fitness wearables continue to unlock potential for endurance athletes with unparalleled performance benefits Amazfit, a leading global smart wearable brand by Zepp Health (NYSE:ZEPP), today is excited to announce that HYROX champions Meg Jacoby and Hunter McIntyre have been added to Amazfit's growing roster of international athletes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240912022365/en/Zepp Health's Amazfit smartwatches and fitness wearables continue to unlock potential for endurance athletes with unparalleled performance benefits (Photo: Business Wire) This follows the recent ann
MILPITAS, Calif., Sept. 6, 2024 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE:ZEPP), a global leader in smart wearables and health technology, today announced that it will change the ratio of its American depositary shares ("ADSs") to its Class A ordinary shares (the "ADS Ratio") from one (1) ADS representing four (4) Class A ordinary shares to one (1) ADS representing sixteen (16) Class A ordinary shares. For the Company's ADS holders, the change in the ADS Ratio will have the same effect as a one-for-four reverse ADS split. A post-effective amendment to the ADS Registration Statement on Form F-6 will be filed with the SEC to reflect the change in the ADS R
-Powered by Zepp Health, the T-Rex 3 Combines Durability with Advanced Privacy Features for Everyday Adventurers BERLIN, Sept. 6, 2024 /PRNewswire/ -- Amazfit, a leading global smart wearable brand by Zepp Health (NYSE:ZEPP), today unveiled the Amazfit T-Rex 3 smartwatch at the IFA Berlin trade event. Designed for the modern explorer, the Amazfit T-Rex 3 combines military-grade durability, cutting-edge outdoor navigation features, and unparalleled battery life, making it the perfect companion for those who seek adventure in their everyday lives. Key Product Differentiators Design: The AMOLED display is 16% larger and 100% brighter than the previous generation, while the body is upgraded wit
MILPITAS, Calif., Sept. 3, 2024 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE:ZEPP), a global leader in smart wearables and health technology, today announced that its board of directors (the "Board") has appointed Mr. Alain Lam, Mr. Mike Yan Yeung, and Mr. Meihui Fan as new directors, effective from Sep. 1, 2024. Mr. Lam is the CFO of Xiaomi Group ("Xiaomi"), with a wealth of experience in finance, capital markets and corporate governance. Mr. Yeung is the COO of Zepp Health and has a broad range of experience in technology MNCs, including Microsoft and Oracle. Mr. Fan is the CTO of the Company, and he is also a member of the Company's founding team. Mr. De
Zepp Health's Amazfit & HYROX Announce Partnership Reaching Over 300,000Participants Per Season Across EU and US regions MILPITAS, Calif. , Aug. 29, 2024 /PRNewswire/ -- HYROX, the World Series of Fitness Racing, a Time 100 Most Influential Companies in the World 2024 Winner has today announced its partnership with Zepp Health Corporation ("Zepp Health") (NYSE:ZEPP), a global leader in smart wearables and health technology, through its smart wearable brand, Amazfit. This two-year partnership will see Amazfit serve as the Official Wearable and Timekeeping partner of HYROX, aiming to aid athletes' training regime, and unlock further potential by providing a sophisticated, yet user- friendly,
MILPITAS, Calif., Aug. 21, 2024 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE:ZEPP) today reported revenues of US$40.6 million; a basic and diluted net loss per share of US$0.04; and a basic and diluted net loss per ADS of US$0.17 for the second quarter ended June 30, 2024; adjusted basic and diluted net loss per share of US$0.04; and adjusted basic and diluted net loss per ADS of US$0.15. Each ADS represents four Class A ordinary shares. Starting from the second quarter of 2024, the Company changed its reporting currency from Renminbi ("RMB") to U.S.dollar ("US$"), to reduce the impact of increased volatility of the RMB to US$ exchange rate on the Company's report
6-K - Zepp Health Corp (0001720446) (Filer)
6-K - Zepp Health Corp (0001720446) (Filer)
F-6 POS - Zepp Health Corp (0001720446) (Subject)
6-K - Zepp Health Corp (0001720446) (Filer)
6-K - Zepp Health Corp (0001720446) (Filer)
6-K - Zepp Health Corp (0001720446) (Filer)
20-F/A - Zepp Health Corp (0001720446) (Filer)
6-K - Zepp Health Corp (0001720446) (Filer)
20-F - Zepp Health Corp (0001720446) (Filer)
6-K - Zepp Health Corp (0001720446) (Filer)
MILPITAS, Calif., Nov. 18, 2024 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE:ZEPP) today reported revenues of US$42.5 million; a basic and diluted net loss per share of US$0.05; and a basic and diluted net loss per ADS of US$0.82 for the third quarter ended September 30, 2024; adjusted basic and diluted net loss per share of US$0.05; and adjusted basic and diluted net loss per ADS of US$0.78. Each ADS represents sixteen Class A ordinary shares. Mr. Wang 'Wayne' Huang, Chairman and CEO of Zepp, commented, "I'm pleased to report that this quarter our Amazfit branded sales had a 10% quarter-over-quarter increase, the highest sequential growth we've achieved this year
Earnings Call Scheduled for 8:30 p.m. ET on November 18, 2024 MILPITAS, Calif., Nov. 5, 2024 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE:ZEPP), a global leader in smart wearables and health technology, today announced that it will report its third quarter 2024 unaudited financial results after the market close on Monday, November 18, 2024. Management will hold a conference call at 8:30 p.m. Eastern Time on Monday, November 18, 2024. Listeners may access the call by dialing: US (Toll Free): +1-888-346-8982 International: +1-412-902-4272 Mainland China (Toll Free): 400-120-1203 Hong Kong (Toll Free): 800-905-945 Hong Kong: +852-3018-4992 Participants should
MILPITAS, Calif., Aug. 21, 2024 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE:ZEPP) today reported revenues of US$40.6 million; a basic and diluted net loss per share of US$0.04; and a basic and diluted net loss per ADS of US$0.17 for the second quarter ended June 30, 2024; adjusted basic and diluted net loss per share of US$0.04; and adjusted basic and diluted net loss per ADS of US$0.15. Each ADS represents four Class A ordinary shares. Starting from the second quarter of 2024, the Company changed its reporting currency from Renminbi ("RMB") to U.S.dollar ("US$"), to reduce the impact of increased volatility of the RMB to US$ exchange rate on the Company's report
Earnings Call Scheduled for 9:30 p.m. ET on August 21, 2024 MILPITAS, Calif., Aug. 8, 2024 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE:ZEPP), a cloud-based healthcare services provider with world-leading smart wearable technology, today announced that it will report its second quarter 2024 unaudited financial results after the market close on Wednesday, August 21, 2024. Management will hold a conference call at 9:30 p.m. Eastern Time on Wednesday, August 21, 2024 (9:30 a.m. Beijing Time on August 22, 2024). Listeners may access the call by dialing: US (Toll Free): +1-888-346-8982 International: +1-412-902-4272 Mainland China (Toll Free): 400-120-1203 Hong
MILPITAS, Calif., May 20, 2024 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE:ZEPP) today reported revenues of US$39.8 million; a basic and diluted net loss per share of US$0.06; and a basic and diluted net loss per ADS of US$0.23 for the first quarter ended March 31, 2024; adjusted basic and diluted net loss per share of US$0.05; and adjusted basic and diluted net loss per ADS of US$0.19. Each ADS represents four Class A ordinary shares. Mr. Wang 'Wayne' Huang, Chairman and CEO of Zepp, commented, "In the first quarter of 2024, our revenue came broadly in line with our guidance. Our gross margin performance reached a record high, and our self-branded product sales
Earnings Call Scheduled for 7:00 p.m. ET on May 20, 2024 MILPITAS, Calif., May 8, 2024 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE:ZEPP), a cloud-based healthcare services provider with world-leading smart wearable technology, today announced that it will report its first quarter 2024 unaudited financial results after the market close on Monday, May 20, 2024. Management will hold a conference call at 7:00 p.m. Eastern Time on Monday, May 20, 2024 (7:00 a.m. Beijing Time on May 21, 2024). Listeners may access the call by dialing: US (Toll Free): +1-888-346-8982 International: +1-412-902-4272 Mainland China (Toll Free): 400-120-1203 Hong Kong (Toll Free): 80
MILPITAS, Calif., March 18, 2024 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE:ZEPP) today reported revenues of US$84.5 million (RMB0.6 billion); a basic and diluted net loss per share of US$0.005 (RMB0.03); and a basic and diluted net loss per ADS of US$0.02 (RMB0.14) for the fourth quarter ended December 31, 2023; adjusted basic and diluted net income per share of US$0.002 (RMB0.01); and adjusted basic and diluted net income per ADS of US$0.01 (RMB0.06). Each ADS represents four Class A ordinary shares. Mr. Wang 'Wayne' Huang, Chairman and CEO of Zepp, commented, "In the fourth quarter, we continued to make substantial progress in our strategic transformation, a
Earnings Call Scheduled for 7:00 p.m. ET on March 18, 2024 AMSTERDAM, March 7, 2024 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE:ZEPP), a cloud-based healthcare services provider with world-leading smart wearable technology, today announced that it will report its fourth quarter and full year 2023 unaudited financial results after the market close on Monday, March 18, 2024. Management will hold a conference call at 7:00 p.m. Eastern Time on Monday, March 18, 2024 (7:00 a.m. Beijing Time on March 19, 2024). Listeners may access the call by dialing: US (Toll Free): +1-888-346-8982 International: +1-412-902-4272 Mainland China (Toll Free): 400-120-1203 Hong Ko
AMSTERDAM, Nov. 20, 2023 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE:ZEPP) today reported revenues of RMB0.6 billion (US$82.5 million); a basic and diluted net income per share of RMB0.01 (US$0.002); and a basic and diluted net income per ADS of RMB0.05 (US$0.01) for the third quarter ended September 30, 2023. Each ADS represents four Class A ordinary shares. Mr. Wayne Wang Huang, Chairman and CEO of Zepp, commented, "In the third quarter, we achieved a business turnaround, returning to profitability after six loss-making quarters. Despite a year-over-year revenue decline, our high-margin self-branded products' contribution to our top line grew to approximately 8
AMSTERDAM, Aug. 21, 2023 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE:ZEPP) today reported revenues of RMB0.65 billion (US$89.4 million); a basic and diluted net loss per share of RMB0.29 (US$0.04); and a basic and diluted net loss per ADS of RMB1.15 (US$0.16) for the second quarter ended June 30, 2023. Each ADS represents four Class A ordinary shares. "In the second quarter of 2023, we were delighted to witness our strategic transformation from a company heavily reliant on a single customer for revenue to becoming a self-reliant, global smart wearable and healthcare solution provider yielding early success, as our self-branded products contributed 68% of our top l
Gainers Actelis Networks (NASDAQ:ASNS) shares increased by 861.8% to $4.52 during Wednesday's pre-market session. The company's market cap stands at $15.1 million. Hewlett Packard (NYSE:HPE) shares rose 16.19% to $20.45. The company's market cap stands at $26.5 billion. The company's, Q2 earnings came out yesterday. Zepp Health (NYSE:ZEPP) stock increased by 15.23% to $0.87. The company's market cap stands at $51.9 million. Abits Group (NASDAQ:ABTS) stock increased by 12.64% to $0.71. The company's market cap stands at $25.2 million. CrowdStrike Holdings (NASDAQ:CRWD) shares rose 11.42% to $340.5. The company's market cap stands at $82.8 billion. The company's, Q1 earnings came out yest
Zepp Health (NYSE:ZEPP) reported quarterly Adj losses of $(0.19) per ADS which missed the analyst consensus estimate of $(0.03) by 533.33 percent. This is a 29.63 percent increase over losses of $(0.27) per ADS from the same period last year. The company reported quarterly sales of $39.80 million which missed the analyst consensus estimate of $46.24 million by 13.93 percent. This is a 57.64 percent decrease over sales of $93.95 million the same period last year.
Gainers Akoustis Technologies (NASDAQ:AKTS) shares moved upwards by 7.5% to $0.17 during Monday's after-market session. The market value of their outstanding shares is at $16.7 million. Cheetah Mobile (NYSE:CMCM) stock rose 6.12% to $5.89. The market value of their outstanding shares is at $176.0 million. Presto Automation (NASDAQ:PRST) shares increased by 5.55% to $0.19. The company's market cap stands at $19.7 million. As per the news, the Q3 earnings report came out today. Inseego (NASDAQ:INSG) shares moved upwards by 4.74% to $6.4. The market value of their outstanding shares is at $76.0 million. Clearwater Analytics Hldg (NYSE:CWAN) stock moved upwards by 4.66% to $20.21. The marke
Zepp Health Corporation ("Zepp" or the "Company") (NYSE:ZEPP), a global leader in smart wearables and health technology, today announced that it has received a letter from the New York Stock Exchange (the "NYSE") dated April 30, 2024, notifying Zepp that it is below compliance standards due to the trading price of Zepp's American depositary shares (the "ADSs").
-Redefining Athletic Recovery & Performance Monitoring, with Global Rollout AheadMILPITAS, Calif., April 30, 2024 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health") (NYSE:ZEPP), a global leader in smart wearables and health technology, today announced the availability of the Amazfit Helio Ring. Athletes in the United States will be able to purchase this smart ring on May 15th, 2024 - either as part of a bundle with the Amazfit Cheetah Pro or Amazfit T-Rex Ultra or as an independent purchase, via the official Amazfit website in the United States. Priced at $299.99, the Amazfit Helio Ring offers unparalleled insights into athletic performance and recovery. The initial inventory carries li
Shares of Peraso Inc. (NASDAQ:PRSO) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter EPS results. Peraso posted a quarterly loss of $8.52 per share, versus analysts’ estimates for a loss of $3.76 per share. The company’s quarterly sales came in at $1.83 million versus expectations of $1.70 million. Peraso shares tumbled 23.3% to $1.32 on Tuesday. Here are some other stocks moving in today's mid-day session. Gainers Ontrak, Inc. (NASDAQ:OTRK) shares climbed 197.8% to $0.5660 ahead of the company's presentation at the 36th Annual Roth Conference. Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) gained 97.3% to $20.99 after the company anno
Gainers BitFuFu (NASDAQ:FUFU) stock increased by 22.5% to $5.0 during Tuesday's regular session. The market value of their outstanding shares is at $814.4 million. Movella Holdings (NASDAQ:MVLA) shares increased by 22.18% to $0.33. The company's market cap stands at $16.7 million. Spectaire Holdings (NASDAQ:SPEC) stock increased by 20.76% to $1.26. The company's market cap stands at $19.2 million. Veritone (NASDAQ:VERI) shares increased by 17.97% to $4.07. The market value of their outstanding shares is at $151.1 million. Akoustis Technologies (NASDAQ:AKTS) stock increased by 13.9% to $0.62. The company's market cap stands at $60.6 million. My Size (NASDAQ:MYSZ) shares rose 11.66% to $
SC 13G/A - Zepp Health Corp (0001720446) (Subject)
SC 13G/A - Zepp Health Corp (0001720446) (Subject)
SC 13G/A - Zepp Health Corp (0001720446) (Subject)
SC 13G/A - Zepp Health Corp (0001720446) (Subject)
SC 13G/A - Zepp Health Corp (0001720446) (Subject)
SC 13G/A - Zepp Health Corp (0001720446) (Subject)
SC 13G/A - Zepp Health Corp (0001720446) (Subject)
SC 13G/A - Zepp Health Corp (0001720446) (Subject)
SC 13G/A - Zepp Health Corp (0001720446) (Subject)
SC 13G/A - Zepp Health Corp (0001720446) (Subject)